Skip to main content
. Author manuscript; available in PMC: 2012 Mar 24.
Published in final edited form as: Blood. 2003 Nov 20;103(6):2332–2336. doi: 10.1182/blood-2003-09-3064

Figure 5. Effect of rituximab on clonogenic MM progenitors in vitro.

Figure 5

MM colony formation following treatment of bone marrow mononuclear cells depleted of CD34+ and CD138+ cells with rituximab or 10% human serum (compl.). Results are presented as a percentage of the untreated control group. P < .01 for the rituximab and rituximab plus complement groups compared to the untreated (control) group by Student t test (n = 3).